Connor, Clark & Lunn Investment Management (CC&L)
AVEO

Connor, Clark & Lunn Investment Management (CC&L)’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-21,563
Closed -$177K – 1499
2022
Q3 		$177K Buy
+21,563
New +$166K ﹤0.01% 1003
2021
Q4 		– Sell
-14,742
Closed -$91K – 1264
2021
Q3 		$91K Buy
+14,742
New +$88.2K ﹤0.01% 987
2017
Q2 		– Sell
-1,850
Closed -$11K – 1011
2017
Q1 		$11K Hold
1,850
– – ﹤0.01% 891
2016
Q4 		$10K Hold
1,850
– – ﹤0.01% 873
2016
Q3 		$16K Hold
1,850
– – ﹤0.01% 823
2016
Q2 		$18K Hold
1,850
– – ﹤0.01% 854
2016
Q1 		$17K Sell
1,850
-1,580
-46% -$15.6K ﹤0.01% 815
2015
Q4 		$43K Buy
3,430
+1,400
+69% +$16.6K ﹤0.01% 794
2015
Q3 		$25K Sell
2,030
-1,170
-37% -$16.9K ﹤0.01% 701
2015
Q2 		$56K Sell
3,200
-3,960
-55% -$71.3K ﹤0.01% 607
2015
Q1 		$104K Buy
7,160
+1,670
+30% +$18.2K ﹤0.01% 533
2014
Q4 		$46K Hold
5,490
– – ﹤0.01% 566
2014
Q3 		$61K Hold
5,490
– – ﹤0.01% 533
2014
Q2 		$107K Sell
5,490
-130
-2% -$1.69K ﹤0.01% 510
2014
Q1 		$93K Buy
+5,620
New +$101K ﹤0.01% 654
2013
Q4 		– Sell
-3,580
Closed -$76K – 780
2013
Q3 		$76K Buy
+3,580
New +$82K ﹤0.01% 493

Other funds holding AVEO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s AVEO Position: Q4 2022 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q4 2022, closing a stake of 21,563 shares — an estimated $177K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in AVEO in Q3 2013 and held it in 16 quarters. The position peaked at $177K in Q3 2022. 110 funds tracked by Wall St. Rank hold AVEO as of Q4 2022.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining AVEO Pharmaceuticals, Inc. position as of Q4 2022 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 21,563 AVEO Pharmaceuticals, Inc. shares in Q4 2022, an estimated $177K.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in AVEO Pharmaceuticals, Inc. in Q3 2013 and held it in 16 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s AVEO Pharmaceuticals, Inc. position peaked at $177K in Q3 2022.
  • 110 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q4 2022.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q4 2022, filed 10 Feb 2023.